Literature DB >> 7138740

Urinary excretion of aspirin.

B Elliot Cham, J H Dykman, F Bochner.   

Abstract

Six human volunteers were each given single oral doses of aspirin (ASA) ranging from 300-1,500 mg. The unchanged ASA excreted in the urine was proportional to dose and urinary pH. The mean percent (+/- s.d.) of dose excreted was 1.9 +/- 0.67. The clearance for ASA was 1.42 +/- 0.28 1/h. The rate of in vitro hydrolysis of ASA to salicylic acid in urine at 37 degrees C was 4 micrograms/min for an initial ASA concentration of 7.5 mg in 100 ml human urine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138740      PMCID: PMC1427592          DOI: 10.1111/j.1365-2125.1982.tb02030.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

2.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

3.  Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in urine.

Authors:  B E Cham; F Bochner; D M Imhoff; D Johns; M Rowland
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

4.  Determination of acetylsalicylic acid and salicylic acid in plasma.

Authors:  M Rowland; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

5.  Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

6.  Urinary excretion of acetylsalicylic acid in man.

Authors:  A J Cummings; M L King
Journal:  Nature       Date:  1966-02-05       Impact factor: 49.962

7.  Gentisuric acid: metabolic formation in animals and identification as a metabolite of aspirin in man.

Authors:  J T Wilson; R L Howell; M W Holladay; G M Brilis; J Chrastil; J T Watson; D F Taber
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

8.  Measurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assay.

Authors:  B E Cham; L Ross-Lee; F Bochner; D M Imhoff
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

  8 in total
  2 in total

1.  Optimal dual antiplatelet therapy strategy in elderly patients with acute coronary syndrome.

Authors:  Monica Verdoia; Rocco Gioscia; Giuseppe De Luca
Journal:  J Geriatr Cardiol       Date:  2021-03-28       Impact factor: 3.327

2.  Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy.

Authors:  Oisín N Kavanagh
Journal:  Ther Adv Drug Saf       Date:  2022-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.